Boston Trust Walden Corp Viatris Inc Transaction History

Boston Trust Walden Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 21, 2021	SELL	$13.59 - $18.54 $137,422 - $187,476	-10,112 Closed	0 $0
Q4 2020 Jan 15, 2021	BUY	$14.3 - $18.74 $144,601 - $189,498	10,112 New	10,112 $189,000

1,103

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.5B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

Stay updated on Boston Trust Walden Corp with notifications on news.